Lower urinary tract symptoms (LUTS) may be a sign of aging rather than a consequence of benign prostatic enlargement (BPE) or benign prostatic obstruction (BPO).
Medical or invasive treatments should address the bothersome symptoms and the quality of life of patients. Alpha blockers and 5-alpha reductase inhibitors are most frequently used in benign prostatic hyperplasia (BPH) medical treatments, whereas Transurethral Resection of the Prostate (TURP) remains the "gold standard" for surgical treatments. Several minimal invasive treatments are emerging with promising outcomes.
Written by:
Pinheiro LC, Martins Pisco J. Are you the author?
Saint Louis Hospital, Department of Interventional Radiology, Lisbon, Portugal.
Reference: Tech Vasc Interv Radiol. 2012 Dec;15(4):256-60.
doi: 10.1053/j.tvir.2012.09.004
PubMed Abstract
PMID: 23244720
